Abstract
Endothelial cell injury is considered to play a critical role for development and progression of atherosclerosis as well as for complications after percutaneous coronary artery interventions in patients with coronary disease. Through the course of human life, the endothelium is constantly replaced and exposure to endothelial cell damaging stimuli, such as cardiovascular risk factors, requires a substantially faster repair and replacement response in order to maintain endothelial integrity and function. Moreover, after coronary interventions, the induced vascular injury requires a fast and efficient re-endothelialization in order to prevent thrombotic events. The promotion of endothelial repair and re-endothelialization responses in patients with cardiovascular disease is therefore a therapeutic target of high interest.
In this review we will critically summarize novel insights into the vascular repair process, as well as the tightly linked mechanisms of adverse vascular remodeling. We will address the roles of resident vascular cell types, as well as circulating mononuclear cell populations, microvesicles and soluble mediators for the vascular repair response.
A better understanding of the mechanisms limiting vascular repair in patients with cardiovascular disease may provide novel opportunities for therapeutic interventions aiming to promote the maintenance of vascular integrity.
Keywords: Endothelium, vascular repair, vascular lesion, vascular injury, adverse remodeling.
Current Pharmaceutical Design
Title:Novel Insights into Vascular Repair Mechanisms
Volume: 20 Issue: 14
Author(s): Nicolle Krankel, Thomas F. Luscher and Ulf Landmesser
Affiliation:
Keywords: Endothelium, vascular repair, vascular lesion, vascular injury, adverse remodeling.
Abstract: Endothelial cell injury is considered to play a critical role for development and progression of atherosclerosis as well as for complications after percutaneous coronary artery interventions in patients with coronary disease. Through the course of human life, the endothelium is constantly replaced and exposure to endothelial cell damaging stimuli, such as cardiovascular risk factors, requires a substantially faster repair and replacement response in order to maintain endothelial integrity and function. Moreover, after coronary interventions, the induced vascular injury requires a fast and efficient re-endothelialization in order to prevent thrombotic events. The promotion of endothelial repair and re-endothelialization responses in patients with cardiovascular disease is therefore a therapeutic target of high interest.
In this review we will critically summarize novel insights into the vascular repair process, as well as the tightly linked mechanisms of adverse vascular remodeling. We will address the roles of resident vascular cell types, as well as circulating mononuclear cell populations, microvesicles and soluble mediators for the vascular repair response.
A better understanding of the mechanisms limiting vascular repair in patients with cardiovascular disease may provide novel opportunities for therapeutic interventions aiming to promote the maintenance of vascular integrity.
Export Options
About this article
Cite this article as:
Krankel Nicolle, Luscher F. Thomas and Landmesser Ulf, Novel Insights into Vascular Repair Mechanisms, Current Pharmaceutical Design 2014; 20 (14) . https://dx.doi.org/10.2174/13816128113199990478
DOI https://dx.doi.org/10.2174/13816128113199990478 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MicroRNAs in the Pathobiology of Multiple Myeloma
Current Cancer Drug Targets Galectin-9 in Cancer Therapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Classification of Sarcomas Using Bioinformatics and Molecular Profiling
Current Pharmaceutical Biotechnology Oncologic Imaging End-Points for the Assessment of Therapy Response
Recent Patents on Anti-Cancer Drug Discovery Application of Phage Display Technology to Cancer Research
Current Pharmaceutical Biotechnology Cell-penetrating Peptide-based Intelligent Liposomal Systems for Enhanced Drug Delivery
Current Pharmaceutical Biotechnology Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance
Mini-Reviews in Medicinal Chemistry Colloidal Polymeric Nanoparticles and Brain Drug Delivery
Current Drug Delivery Advances in Interleukin-12 Gene Therapy for Acquired Liver Diseases
Current Gene Therapy Update on the Rheumatologic Manifestations of Malignancy
Current Cancer Therapy Reviews Gemcitabine: A Critical Nucleoside for Cancer Therapy
Current Medicinal Chemistry Symmetry-Based Self-Assembled Nanotubes Constructed Using Native Protein Structures: The Key Role of Flexible Linkers
Protein & Peptide Letters Intrinsic Disorder and Function of the HIV-1 Tat Protein
Protein & Peptide Letters Epithelial Mesenchymal Transition in Cancer Progression: Prev entive Phytochemicals
Recent Patents on Anti-Cancer Drug Discovery P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
Current Cancer Drug Targets Mechanisms of Anti-retroviral Drug Resistance: Implications for Novel Drug Discovery and Development
Infectious Disorders - Drug Targets Imaging Features of Primary Tumors of the Hand
Current Medical Imaging Recent Advances in the New Generation Taxane Anticancer Agents
Medicinal Chemistry Significance of Various Experimental Models and Assay Techniques in Cancer Diagnosis
Mini-Reviews in Medicinal Chemistry Therapeutics Based on microRNA: A New Approach for Liver Cancer
Current Genomics